Explore more publications!

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on March 17, 2026

Dr. Renee Thompson Announced as a Pre-Conference Speaker at the  2026 AONL Annual Conference in Chicago
The Surprising Connection Between Addiction in Animals & People
South Florida Founder Kerry Meikle Leads Arsahd Diaper Drive Supporting Miami Diaper Bank
Ascension St. Vincent’s Treats 1,000th Patient with Pulsed Field Ablation for Atrial Fibrillation
Global Innovative Platforms (GIPL) Announces OTCID™ Quotation
CMG Containers Expands Refrigerated Containers for Sale to Support Temperature-Controlled Storage and Transport
Physician-Governed Innovative Health ACO Established to Advance Clinical Collaboration and Value-Based Care Readiness
COPILOT Provider Services Rebrands as Elusa Health, Launching New Identity Built on Clarity and Access
NatureGlyco Blood Support Claims Evaluated: The Proven Glyco Care Formula for Healthy Blood Sugar Support
Mesoblast to Host R&D Day on April 8, 2026
DentaBiome Claims Evaluated: 2026 Oral Postbiotic Consumer Warning Report Issued
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
ORIC® Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Galapagos Receives Transparency Notification from Bank of America
Galapagos ontvangt transparantieverklaring van Bank of America   
Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions